- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabis and multiple sclerosis
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume -, Issue -, Pages 1-6
Publisher
Informa UK Limited
Online
2020-06-09
DOI
10.1080/14737175.2020.1776610
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictors of Nabiximols (Sativex®) discontinuation over long-term follow-up: a real-life study
- (2020) Antonio Carotenuto et al. JOURNAL OF NEUROLOGY
- Adverse outcome pathway of developmental neurotoxicity resulting from prenatal exposures to cannabis contaminated with organophosphate pesticide residues
- (2019) Maxwell C.K. Leung et al. REPRODUCTIVE TOXICOLOGY
- Cannabinoid therapy in epilepsy
- (2019) Santoshi Billakota et al. CURRENT OPINION IN NEUROLOGY
- Key elements of legal environments for medical use of cannabis in different countries
- (2019) Werner Knöss et al. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz
- The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews
- (2018) Suzanne Nielsen et al. Current Neurology and Neuroscience Reports
- Practical considerations in medical cannabis administration and dosing
- (2018) Caroline A. MacCallum et al. European Journal of Internal Medicine
- Medical use of cannabis and cannabinoids containing products – Regulations in Europe and North America
- (2018) Ran Abuhasira et al. European Journal of Internal Medicine
- Medical cannabis: A forward vision for the clinician
- (2018) M.A. Fitzcharles et al. EUROPEAN JOURNAL OF PAIN
- Sativex® as Add-on therapy Vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
- (2018) Jolana Markovà et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Cannabis use predicts risks of heart failure and cerebrovascular accidents
- (2018) Aditi Kalla et al. Journal of Cardiovascular Medicine
- Balance worsening associated with nabiximols in multiple sclerosis
- (2018) Letizia Castelli et al. Multiple Sclerosis Journal
- Balance worsening associated with nabiximols in multiple sclerosis
- (2018) Letizia Castelli et al. Multiple Sclerosis Journal
- The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis-related spasticity
- (2018) Elisabeth G. Celius et al. Brain and Behavior
- Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer
- (2018) Melissa Badowski et al. Therapeutics and Clinical Risk Management
- A review of the effects of baclofen and of THC:CBD oromucosal spray on spasticity-related walking impairment in multiple sclerosis
- (2018) Rafael Arroyo González Expert Review of Neurotherapeutics
- Intrathecal baclofen for multiple sclerosis related spasticity: A twenty year experience
- (2018) Yezen Sammaraiee et al. Multiple Sclerosis and Related Disorders
- The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law
- (2017) Alice Mead EPILEPSY & BEHAVIOR
- Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients
- (2017) Sebastian Schimrigk et al. EUROPEAN NEUROLOGY
- Efficacy and safety of oral baclofen in the management of spasticity: A rationale for intrathecal baclofen
- (2017) P Ertzgaard et al. JOURNAL OF REHABILITATION MEDICINE
- THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study
- (2017) Giorgia Teresa Maniscalco et al. NEUROLOGICAL SCIENCES
- Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective study
- (2017) Pamela Latino et al. NEUROLOGICAL SCIENCES
- Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)
- (2017) Silvia Messina et al. PLoS One
- Cannabis use, attitudes, and legal status in the U.S.: A review
- (2017) Hannah Carliner et al. PREVENTIVE MEDICINE
- Evaluating the public health impacts of legalizing recreational cannabis use in the United States
- (2016) Wayne Hall et al. ADDICTION
- Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice
- (2016) Patrick Vermersch et al. EUROPEAN NEUROLOGY
- Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
- (2016) F Patti et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper
- (2016) Susana Otero-Romero et al. Multiple Sclerosis Journal
- Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper
- (2016) Susana Otero-Romero et al. Multiple Sclerosis Journal
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment
- (2015) Robert J. Tait et al. CLINICAL TOXICOLOGY
- Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis
- (2015) Letizia Leocani et al. JOURNAL OF NEUROLOGY
- Walking improvements with nabiximols in patients with multiple sclerosis
- (2015) G. Coghe et al. JOURNAL OF NEUROLOGY
- Efficacy and safety of nabiximols (Sativex®) on multiple sclerosis spasticity in a real-life Italian monocentric study
- (2015) Laura Ferrè et al. NEUROLOGICAL SCIENCES
- The Endocannabinoid System and its Modulation by Phytocannabinoids
- (2015) Vincenzo Di Marzo et al. Neurotherapeutics
- Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity
- (2014) Peter Flachenecker et al. EUROPEAN NEUROLOGY
- Adverse Health Effects of Marijuana Use
- (2014) Nora D. Volkow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System
- (2014) John M. McPartland et al. PLoS One
- Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
- (2013) Stephen M. Stout et al. DRUG METABOLISM REVIEWS
- Colorado Family Physicians' Attitudes Toward Medical Marijuana
- (2013) E. Kondrad et al. Journal of the American Board of Family Medicine
- Medical marijuana: Medical necessity versus political agenda
- (2013) Peter A. Clark et al. MEDICAL SCIENCE MONITOR
- Medicinal Use of Marijuana — Polling Results
- (2013) Jonathan N. Adler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Spasticity Management in Multiple Sclerosis
- (2013) Christina Hughes et al. Physical Medicine and Rehabilitation Clinics of North America
- Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
- (2012) J. Corey-Bloom et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Evaluation of the safety and tolerability profile of Sativex®: is it reassuring enough?
- (2012) Derick Wade Expert Review of Neurotherapeutics
- A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
- (2012) R. M. Langford et al. JOURNAL OF NEUROLOGY
- MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
- (2012) John Peter Zajicek et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Why do cannabinoid receptors have more than one endogenous ligand?
- (2012) V. Di Marzo et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
- (2011) A. Novotna et al. EUROPEAN JOURNAL OF NEUROLOGY
- Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis
- (2010) RBC Kavia et al. Multiple Sclerosis Journal
- A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
- (2010) C. Collin et al. NEUROLOGICAL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started